Joseph Antony, Montiague Raul, Effendi Ali R, Urbanska Renata A, Vogel Stephen, Winnie Alon P, Rabito Sara F
Department of Anesthesiology, John H. Stroger, Jr. Hospital of Cook County, University of Illinois College of Medicine, Chicago, USA.
Anesthesiology. 2005 May;102(5):977-84. doi: 10.1097/00000542-200505000-00017.
The cardiotoxic mechanism of local anesthetics may include interruption of cardiac sympathetic reflexes. The authors undertook this investigation to determine if clinically relevant concentrations of bupivacaine and levobupivacaine interfere with exocytotic norepinephrine release from cardiac sympathetic nerve endings.
Rat atria were prepared for measurements of twitch contractile force and [H]-norepinephrine release. After nerve endings were loaded with [H]-norepinephrine, the tissue was electrically stimulated in 5-min episodes during 10 10-min sampling periods. After each period, a sample of bath fluid was analyzed for radioactivity and [H]-norepinephrine release was expressed as a fraction of tissue counts. Atria were exposed to buffer alone during sampling periods 1 and 2 (S1 and S2). Control atria received saline (100 microl each, n = 6 atria) in S3-S10. Experimental groups (n = 6 per group) received either bupivacaine or levobupivacaine at concentrations (in microM) of 5 (S3-S4), 10 (S5-S6), 30 (S7-S8), and 100 (S9-S10).
Bupivacaine and levobupivacaine decreased stimulation-evoked fractional [H]-norepinephrine release with inhibitory concentration 50% values of 5.1 +/- 0.5 and 6.1 +/- 1.3 microM. The inhibitory effect of both local anesthetics (approximately 70%) approached that of tetrodotoxin. Local anesthetics abolished the twitch contractions of atria with inhibitory concentration 50% values of 12.6 +/- 5.0 microM (bupivacaine) and 15.7 +/- 3.9 microM (levobupivacaine). In separate experiments, tetrodotoxin inhibited twitch contractile force by only 30%.
The results indicate that clinically relevant cardiotoxic concentrations of bupivacaine and levobupivacaine markedly depress cardiac sympathetic neurotransmission. A possible mechanism of local anesthetics in reducing evoked norepinephrine release from sympathetic endings is blockade of tetrodotoxin-sensitive fast sodium channels.
局部麻醉药的心脏毒性机制可能包括干扰心脏交感反射。作者进行此项研究以确定布比卡因和左旋布比卡因的临床相关浓度是否会干扰心脏交感神经末梢去甲肾上腺素的胞吐释放。
制备大鼠心房用于测量抽搐收缩力和[H] - 去甲肾上腺素释放。在神经末梢加载[H] - 去甲肾上腺素后,在10个10分钟的采样期内,以5分钟的间隔对组织进行电刺激。每个时期后,分析一份浴液样本的放射性,[H] - 去甲肾上腺素释放量以组织计数的分数表示。在采样期1和2(S1和S2)期间,心房仅暴露于缓冲液。对照心房在S3 - S10接受生理盐水(每次100微升,n = 6个心房)。实验组(每组n = 6)分别接受浓度(以微摩尔计)为5(S3 - S4)、10(S5 - S6)、30(S7 - S8)和100(S9 - S10)的布比卡因或左旋布比卡因。
布比卡因和左旋布比卡因降低刺激诱发的[H] - 去甲肾上腺素释放分数,其半数抑制浓度值分别为5.1±0.5和6.1±1.3微摩尔。两种局部麻醉药的抑制作用(约70%)接近河豚毒素的抑制作用。局部麻醉药消除心房的抽搐收缩,其半数抑制浓度值分别为12.6±5.0微摩尔(布比卡因)和15.7±3.9微摩尔(左旋布比卡因)。在单独的实验中,河豚毒素仅抑制抽搐收缩力30%。
结果表明,布比卡因和左旋布比卡因的临床相关心脏毒性浓度显著抑制心脏交感神经传递。局部麻醉药减少交感神经末梢诱发的去甲肾上腺素释放的一种可能机制是阻断对河豚毒素敏感的快速钠通道。